Revenue (Tables)

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenues

Our disaggregated revenues were as follows for the periods presented (in thousands):

	Three Months Ended June,				Six Months Ended June 30,
	2022		2021		2022		2021
Royalties	$	405	$	228	$	777	$	521
Grant revenues
Israel Innovation Authority (“IIA”)		-		71		-		169
Total grant revenues		-		71		-		169
Revenues from collaborative agreements
Upfront license fees		4,148		36		9,013		36
Reimbursements, cost-sharing payments		-		177		-		177
Total revenues from collaborative agreements		4,148		213		9,013		213
Total revenue	$	4,553	$	512	$	9,790	$	903

Schedule of Contract with Customer Contract Liability and Receivable

Accounts receivable and other receivable, net, and deferred revenues (contract liabilities) from contracts with customers, including collaboration partners, consisted of the following (in thousands):

	June 30, 2022		December 31, 2021
	(unaudited)
Accounts receivable and other receivable, net (1)(2)	$	532	$	50,640
Deferred revenues (2)		41,500		50,500

(1)	Accounts receivable and other receivable, net, decreased primarily due to the receipt of the $50.0 million upfront payment under the Roche Agreement, received in January 2022. See Note 14 (Commitments and Contingencies).
(2)	Excludes government grants as Lineage has determined government grants are outside the scope of ASU 2014-09 – Revenue from Contracts with Customers (Topic 606).